When Shanghai went into lockdown to prevent the spread of the Omicron COVID-19 variant, our client’s important work in clinical trials had to continue.
To minimize the impact of this unprecedented situation, Almac Clinical Technologies worked closely with our sponsors to develop low-risk, multifaceted solutions to handle each client’s unique set of needs and challenges.

Read how in our new case study.